financetom
Business
financetom
/
Business
/
Automotive Seating Leader Adient Performance Succumbs To Demand Volatility
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Automotive Seating Leader Adient Performance Succumbs To Demand Volatility
Nov 5, 2025 8:29 AM

Adient Plc ( ADNT ) shares fell Wednesday after the company reported mixed financial results for its fourth quarter.

The company posted adjusted earnings of 52 cents per share for the quarter, from 68 cents a year ago, missing analysts' estimates of 53 cents.

The quarterly net sales rose to $3.69 billion from $3.56 billion a year ago, topping expectations of $3.58 billion.

Also Read: This Adient Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

The company reported an adjusted EBITDA margin of 6.1%, down from 6.6% the previous year.

In fiscal 2025, Adient strengthened its market position with key new and replacement contracts, including JIT and foam business for the F-150 and trim and SUV program wins with an Asia-based OEM.

In China, partnerships with local automakers drove growth, with China OEMs contributing nearly 70% of the $1.4 billion in new business booked in Asia.

Adient met its fiscal 2025 commitments despite ongoing industry and macroeconomic challenges. The company said it delivered a solid business performance, effectively offsetting the impacts of tariffs and lower customer production.

For the year, adjusted EBITDA reached $881 million, representing a 6.1% margin, up 10 basis points from fiscal 2024, while free cash flow totaled $204 million.

Segment Performance

By region, the Americas delivered $1.79 billion in sales with $111 million in adjusted EBITDA, reflecting a 6.2% margin. Europe, Middle East, and Africa (EMEA) posted $1.15 billion in sales and $31 million in adjusted EBITDA, for a 2.7% margin, while Asia contributed $783 million in sales and $106 million in adjusted EBITDA, yielding a robust 13.5% margin.

Liquidity and Capital Allocation

Adient ended fiscal 2025 with $958 million in cash and total liquidity of $1.8 billion. The company repurchased $50 million of shares in the fourth quarter and $125 million for the full year, about 7% of shares outstanding. About $135 million remains under its current buyback authorization. After quarter end, Adient refinanced its ABL revolver, extending its maturity to 2030.

Outlook

For fiscal 2026, Adient expects sales of about $14.4 billion, capital expenditures of approximately $300 million, and free cash flow of around $90 million.

Adient expects adjusted EBITDA of around $845 million for fiscal 2026, assuming no changes to existing tariff policies, with most tariff-related costs resolved and no significant impact on previously projected volumes from tariffs.

CEO Commentary

Jerome Dorlack, President and Chief Executive Officer, stated, "We closed the fiscal year with strong momentum, thanks to our resilient operating model and unwavering commitment to execution. Our team's focus and agility enabled us to consistently deliver on our objectives and successfully navigate macro volatility, win significant new business and position the company for sustainable growth in the future."

Price Action: ADNT shares were trading lower by 12.30% to $21.04 at last check Wednesday.

Read Next:

Johnson Controls Sees Record Orders From Soaring Data Centers

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Emerson's quarterly earnings rise on measurement instruments demand
Emerson's quarterly earnings rise on measurement instruments demand
Aug 7, 2024
Aug 7 (Reuters) - Emerson Electric ( EMR ) reported higher third-quarter earnings on Wednesday, aided by demand for its unit which makes valves, regulators and actuators. Emerson's measurement and analytical devices have continued to benefit from manufacturers and end customers across the chemical, oil and gas industries. The company however has pivoted its focus on automation products and services,...
Top Premarket Decliners
Top Premarket Decliners
Aug 7, 2024
07:54 AM EDT, 08/07/2024 (MT Newswires) -- Talis Biomedical ( TLIS ) shares slumped 47% pre-bell Wednesday after Tuesday's 2.5% gain. Emergent BioSolutions ( EBS ) shares fell 35% after reporting weaker Q2 financial results. National Vision ( EYE ) shares dropped 13% following a 2.6% gain in the previous session. Price: 4.75, Change: -4.26, Percent Change: -47.28 ...
New York Times' Q2 Adjusted Earnings, Revenue Rise
New York Times' Q2 Adjusted Earnings, Revenue Rise
Aug 7, 2024
07:52 AM EDT, 08/07/2024 (MT Newswires) -- New York Times ( NYT ) reported Q2 adjusted earnings Wednesday of $0.45 per diluted share, up from $0.38 a year earlier. Analysts polled by Capital IQ expected $0.41. Revenue for the quarter ended June 30 was $625.1 million, up from $590.9 million a year earlier. Analysts surveyed by Capital IQ expected $625.2...
Aurora Cannabis Up in U.S. Pre-Market After Swinging to Fiscal Q1 Profit
Aurora Cannabis Up in U.S. Pre-Market After Swinging to Fiscal Q1 Profit
Aug 7, 2024
07:53 AM EDT, 08/07/2024 (MT Newswires) -- Aurora Cannabis ( ACB ) swung to a profit in the first quarter, booking net income from continuing operations of $4.8 million, reversing a loss of $20.2 million. For the three months ended June 30, revenue increased 12% to $83.4 million, driven by record revenue of $47.2 million from the company's global medical...
Copyright 2023-2026 - www.financetom.com All Rights Reserved